Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for preparing orlistat intermediate by enzymatic technology

A technology for orlistat and enzymatic preparation, which is applied in the field of enzymatic preparation of orlistat intermediates, can solve the problems of high production equipment requirements, high catalyst cost, high corrosion, etc., and achieve an environmentally friendly effect

Active Publication Date: 2018-12-18
ZHEJIANG OCEAN UNIV
View PDF7 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Using the catalyst to prepare (R)-3-hydroxy-tetradecanoic acid methyl ester has a chiral ee value of less than 99%, the cost of the catalyst is relatively high, and the catalytic reaction needs to be carried out under strong acid and high pressure conditions, which requires high production equipment and highly corrosive

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing orlistat intermediate by enzymatic technology
  • Method for preparing orlistat intermediate by enzymatic technology

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] 5 g of the substrate β-carbonyltetradecanoic acid methyl ester was added to a 250 mL reactor, and subsequently, 100 mL containing 0.1 g / L NAD + , 30g / L cell disruption solution containing recombinant short-chain alcohol dehydrogenase, 10g / L cell disruption solution containing recombinant glucose dehydrogenase, 100g / L glucose, and 0.1M phosphate buffer (pH 7.0) were added to the reactor In the process, the solid-liquid ratio of β-carbonyltetradecanoic acid methyl ester to the mixed solution is 50g / L, and the pH automatic control system and 1M Na 2 CO 3 The solution controls the pH of the enzyme reaction to around 7.0. React at 35°C for 12h. The substrate conversion rate is greater than 98%, the product concentration is 49.0g / L, and the chiral ee value of the product is greater than 99%.

Embodiment 2

[0043] 7.5 g of the substrate β-carbonyltetradecanoic acid methyl ester was added to a 250 mL reactor, and subsequently, 100 mL containing 0.1 g / L NAD + , 35g / L cell disruption solution containing recombinant short-chain alcohol dehydrogenase, 10g / L cell disruption solution containing recombinant glucose dehydrogenase, 100g / L glucose, and 0.1M phosphate buffer (pH 7.0) were added to the reactor Among them, the solid-liquid ratio of β-carbonyltetradecanoic acid methyl ester to the mixed solution is 75g / L, and the pH automatic control system and 1M Na 2 CO 3 The solution controls the pH of the enzyme reaction to around 7.0. React at 35°C for 12h. The substrate conversion rate is greater than 96%, the product concentration is 72.0g / L, and the chiral ee value of the product is greater than 99%.

Embodiment 3

[0045] 10 g of the substrate β-carbonyltetradecanoic acid methyl ester was added to a 250 mL reactor, and subsequently, 100 mL containing 0.1 g / L NAD + , 30g / L cell disruption solution containing recombinant short-chain alcohol dehydrogenase, 10g / L cell disruption solution containing recombinant glucose dehydrogenase, 200g / L glucose, and 0.1M phosphate buffer (pH 7.0) were added to the reactor In the process, the solid-liquid ratio of β-carbonyltetradecanoic acid methyl ester to the mixed solution is 100g / L, and the pH automatic control system and 1M Na 2 CO 3 The solution controls the pH of the enzyme reaction to around 7.0. React at 35°C for 12h. The substrate conversion rate is greater than 78%, the product concentration is 78.0g / L, and the chiral ee value of the product is greater than 99%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medicines, and discloses a method for preparing an orlistat intermediate by an enzymatic technology. The method comprises the following steps: synthesisof a short-chain alcohol dehydrogenase original gene, expression of a short-chain alcohol dehydrogenase, cell breaking and enzymatic catalysis. The production of the high-chiral ee value (ee > 99%) orlistat intermediate methyl (R)-3-hydroxytetradecanoate by a short-chain alcohol dehydrogenase catalysis process is sued to substitute a traditional chemical synthesis method, so the production cost and the environmental pollution are reduced. The method for synthesizing the orlistat intermediate has the advantages of mild reaction conditions, fast reaction speed, high reaction yield and chiral eevalue, low production cost, and suitableness for industrial expansion production.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a method for enzymatically preparing an orlistat intermediate. Background technique [0002] Orlistat is currently the only OTC weight loss drug in the world. Orlistat is a long-acting and potent specific gastrointestinal lipase inhibitor, which acts by forming a covalent bond with the active serine site of gastric lipase and pancreatic lipase in the lumen of the stomach and small intestine to inactivate the enzymes Therapeutic effect, inactivated enzymes cannot hydrolyze the fat in food, mainly triglycerides, into absorbable free fatty acids and monoacylglycerols. Undigested triglycerides cannot be absorbed by the body, thereby reducing caloric intake and controlling weight. The drug does not need to be absorbed systemically to be effective. [0003] The structural formula of orlistat: [0004] [0005] According to the structural analysis of orlistat, (R)-β-hydroxy myri...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/70C12N9/04C12P17/02
CPCC12N9/0006C12N15/70C12N2800/22C12P17/02
Inventor 唐云平周亚峰丁国芳余方苗杨最素黄芳芳陈艳
Owner ZHEJIANG OCEAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com